Managing Director-Americas

• Jan 2022 - Present

My role is to bring an in-depth portfolio of WS capabilities to the full spectrum of life sciences clients and stakeholders. Widler & Schiemann supports clients in all aspects (strategy and delivery) of drug development, from manufacturing and pre-clinical studies to post-approval and commercialization support. Widler-Schiemann has provided advisory support and strategy to clients that include regulators such as FDA, EMA, NMPA, and SwissMedic and organizations such as WHO, OECD, CTTI, and ACRES. Widler & Schiemann is headquartered in Zug, Switzerland, with offices in the USA, Germany, and China. Show less

Chief Operating Officer

• Apr 2023 - Present

Ymmunobio AG is a preclinical stage oncology biotech company focused on the development of innovative treatments for cancer patients through new classes of antibodies. Those treatments present a large market potential and broad applicability in solid tumors. As COO, I am leveraging my substantial industry, consulting, and business development experience to advance Ymmunobio's strategy for novel and first-in-class antibody research. Ymmunobio AG is a preclinical stage oncology biotech company focused on the development of innovative treatments for cancer patients through new classes of antibodies. Those treatments present a large market potential and broad applicability in solid tumors. As COO, I am leveraging my substantial industry, consulting, and business development experience to advance Ymmunobio's strategy for novel and first-in-class antibody research.

Founder

• Oct 2020 - Jan 2022

As Founder of Peconic Life Sciences Collaborative, a specialty consulting practice focusing on building value across the Life Sciences R&D ecosystem, I leverage my over thirty years of professional experience, both in the pharmaceutical industry and in consulting & advisory, to shape and deliver transformational and strategic programs across the R&D value chain. I have had the privilege of advising most of the leading biopharmaceutical, medical device, and generic drug companies, across a broad array of functional domains, and my client list includes top leaders across healthcare and life sciences, regulators, non-profits, and industry advocacy groups. Show less

Director, Compliance / Risk Advisory

• Mar 2018 - Oct 2020

Life Sciences Specialist Leader

• Jun 2016 - Feb 2018

I focused on developing and delivering leading edge compliance and risk management solutions. I was specifically involved in developing a regulatory intelligence solution with significant predictive power. I focused on developing and delivering leading edge compliance and risk management solutions. I was specifically involved in developing a regulatory intelligence solution with significant predictive power.

Client Services Partner

• Jun 2015 - Jun 2016

Skyland Analytics is the premier process intelligence, compliance and IT consultancy whose mission is to drive rapid client compliance through a combination of enhanced manufacturing analytics, integrated compliance expertise and industry leading consulting improvement efforts. Skyland Analytics is the premier process intelligence, compliance and IT consultancy whose mission is to drive rapid client compliance through a combination of enhanced manufacturing analytics, integrated compliance expertise and industry leading consulting improvement efforts.

Senior Manager

• Oct 2012 - May 2015

I was responsible for delivering the full complement of Accenture’s consulting expertise to regulated pharmaceutical and biotechnology clients. I was responsible for delivering the full complement of Accenture’s consulting expertise to regulated pharmaceutical and biotechnology clients.

Principal

• Nov 2010 - Oct 2012

Responsible for selling and delivering targeted consulting and technology services to the biopharmaceutical industries. Demonstrated strong revenue building, management and collaboration/mentoring. Responsible for selling and delivering targeted consulting and technology services to the biopharmaceutical industries. Demonstrated strong revenue building, management and collaboration/mentoring.

VP, Strategic Account Planning

• Feb 2009 - Oct 2010

Primary focus was on designing and building a new Strategic Account Management capability for PAREXEL.

Vice President, Client Strategy

• Oct 2007 - Jan 2009

Vice President, Client Strategy at PAREXEL Consulting, a leading drug development consulting organization, and a business unit of PAREXEL International. Marty's role concentrated on driving new opportunities supporting Strategic Partnering in Regulatory Affairs.

Associate Partner, Life Sciences

• 2002 - 2007

Manager, Life Sciences

• Mar 1996 - Jan 2002

Focusing on all aspects of process, technology, and organizational improvement supporting leading biopharmaceutical companies. Focusing on all aspects of process, technology, and organizational improvement supporting leading biopharmaceutical companies.

Process Validation Program Manager, Life Sciences International

• Jun 1993 - Mar 1995

This business unit of Day & Zimmerman, Inc. is dedicated to serving the process and software validation needs of the pharmaceutical, biotech, and device industries. Responsible for the management and coordination of numerous field validation engineering and compliance projects for flagship pharmaceutical companies. This business unit of Day & Zimmerman, Inc. is dedicated to serving the process and software validation needs of the pharmaceutical, biotech, and device industries. Responsible for the management and coordination of numerous field validation engineering and compliance projects for flagship pharmaceutical companies.

Process Development Scientist

• Sep 1987 - Jun 1993

Served in manufacturing and process development capacities at this leading biotechnology company. Served in manufacturing and process development capacities at this leading biotechnology company.